Go Pro
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel Free TLM Stock Alerts

Talisman Metals (TLM) Competitors

GBX 6.35 +0.10 (+1.60%)
As of 08/11/2026 11:36 AM Eastern
Compare

TLM vs. CLBX, APTA, FAB, NSCI, and GENF

Should you buy Talisman Metals stock or one of its competitors? Talisman Metals's main competitors and comparable companies include Cellbxhealth (CLBX), Aptamer Group (APTA), Fusion Antibodies (FAB), NetScientific (NSCI), and Genflow Biosciences (GENF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Talisman Metals compare to Cellbxhealth?

Talisman Metals (LON:TLM) and Cellbxhealth (LON:CLBX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Cellbxhealth's return on equity of 0.00% beat Talisman Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A -32.71% 3.70%
Cellbxhealth N/A N/A N/A

Cellbxhealth has higher revenue and earnings than Talisman Metals. Cellbxhealth is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.51
Cellbxhealth£1.15M13.48N/A-£3.49N/A

In the previous week, Talisman Metals had 1 more articles in the media than Cellbxhealth. MarketBeat recorded 1 mentions for Talisman Metals and 0 mentions for Cellbxhealth. Talisman Metals' average media sentiment score of 0.21 beat Cellbxhealth's score of 0.00 indicating that Talisman Metals is being referred to more favorably in the media.

Company Overall Sentiment
Talisman Metals Neutral
Cellbxhealth Neutral

1.4% of Talisman Metals shares are held by institutional investors. Comparatively, 0.4% of Cellbxhealth shares are held by institutional investors. 95.2% of Talisman Metals shares are held by insiders. Comparatively, 1.2% of Cellbxhealth shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Talisman Metals beats Cellbxhealth on 7 of the 9 factors compared between the two stocks.

How does Talisman Metals compare to Aptamer Group?

Aptamer Group (LON:APTA) and Talisman Metals (LON:TLM) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

Talisman Metals has a net margin of 0.00% compared to Aptamer Group's net margin of -178.52%. Talisman Metals' return on equity of -32.71% beat Aptamer Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Aptamer Group-178.52% -135.35% -44.96%
Talisman Metals N/A -32.71%3.70%

3.3% of Aptamer Group shares are owned by institutional investors. Comparatively, 1.4% of Talisman Metals shares are owned by institutional investors. 7.3% of Aptamer Group shares are owned by company insiders. Comparatively, 95.2% of Talisman Metals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Talisman Metals has lower revenue, but higher earnings than Aptamer Group. Aptamer Group is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aptamer Group£1.38M10.58-£14.17M-£0.11N/A
Talisman MetalsN/AN/A-£1.35M£12.390.51

Aptamer Group has a beta of 0.899, meaning that its share price is 10% less volatile than the broader market. Comparatively, Talisman Metals has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market.

In the previous week, Talisman Metals had 1 more articles in the media than Aptamer Group. MarketBeat recorded 1 mentions for Talisman Metals and 0 mentions for Aptamer Group. Talisman Metals' average media sentiment score of 0.21 beat Aptamer Group's score of 0.00 indicating that Talisman Metals is being referred to more favorably in the news media.

Company Overall Sentiment
Aptamer Group Neutral
Talisman Metals Neutral

Summary

Talisman Metals beats Aptamer Group on 10 of the 12 factors compared between the two stocks.

How does Talisman Metals compare to Fusion Antibodies?

Talisman Metals (LON:TLM) and Fusion Antibodies (LON:FAB) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

In the previous week, Talisman Metals had 1 more articles in the media than Fusion Antibodies. MarketBeat recorded 1 mentions for Talisman Metals and 0 mentions for Fusion Antibodies. Talisman Metals' average media sentiment score of 0.21 beat Fusion Antibodies' score of 0.00 indicating that Talisman Metals is being referred to more favorably in the media.

Company Overall Sentiment
Talisman Metals Neutral
Fusion Antibodies Neutral

Talisman Metals has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market. Comparatively, Fusion Antibodies has a beta of 1.224, indicating that its share price is 22% more volatile than the broader market.

1.4% of Talisman Metals shares are owned by institutional investors. Comparatively, 7.6% of Fusion Antibodies shares are owned by institutional investors. 95.2% of Talisman Metals shares are owned by insiders. Comparatively, 5.9% of Fusion Antibodies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Talisman Metals has a net margin of 0.00% compared to Fusion Antibodies' net margin of -91.92%. Talisman Metals' return on equity of -32.71% beat Fusion Antibodies' return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A -32.71% 3.70%
Fusion Antibodies -91.92%-210.32%-63.78%

Talisman Metals has higher earnings, but lower revenue than Fusion Antibodies. Fusion Antibodies is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.51
Fusion Antibodies£1.60M8.47-£4.10M-£1.50N/A

Summary

Talisman Metals beats Fusion Antibodies on 9 of the 12 factors compared between the two stocks.

How does Talisman Metals compare to NetScientific?

NetScientific (LON:NSCI) and Talisman Metals (LON:TLM) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

NetScientific has a beta of 1.67, suggesting that its stock price is 67% more volatile than the broader market. Comparatively, Talisman Metals has a beta of 0.9, suggesting that its stock price is 10% less volatile than the broader market.

Talisman Metals has a net margin of 0.00% compared to NetScientific's net margin of -182.91%. NetScientific's return on equity of -13.70% beat Talisman Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
NetScientific-182.91% -13.70% -9.42%
Talisman Metals N/A -32.71%3.70%

In the previous week, Talisman Metals had 1 more articles in the media than NetScientific. MarketBeat recorded 1 mentions for Talisman Metals and 0 mentions for NetScientific. Talisman Metals' average media sentiment score of 0.21 beat NetScientific's score of 0.00 indicating that Talisman Metals is being referred to more favorably in the news media.

Company Overall Sentiment
NetScientific Neutral
Talisman Metals Neutral

Talisman Metals has lower revenue, but higher earnings than NetScientific. NetScientific is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NetScientific£1.45M0.00-£2.64M-£0.11N/A
Talisman MetalsN/AN/A-£1.35M£12.390.51

14.7% of NetScientific shares are owned by institutional investors. Comparatively, 1.4% of Talisman Metals shares are owned by institutional investors. 42.4% of NetScientific shares are owned by insiders. Comparatively, 95.2% of Talisman Metals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Talisman Metals beats NetScientific on 8 of the 12 factors compared between the two stocks.

How does Talisman Metals compare to Genflow Biosciences?

Talisman Metals (LON:TLM) and Genflow Biosciences (LON:GENF) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Genflow Biosciences is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.51
Genflow BiosciencesN/AN/A-£1.76M-£0.33N/A

1.4% of Talisman Metals shares are held by institutional investors. Comparatively, 0.1% of Genflow Biosciences shares are held by institutional investors. 95.2% of Talisman Metals shares are held by company insiders. Comparatively, 25.8% of Genflow Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Talisman Metals has a net margin of 0.00% compared to Genflow Biosciences' net margin of -170.64%. Genflow Biosciences' return on equity of 332.06% beat Talisman Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A -32.71% 3.70%
Genflow Biosciences -170.64%332.06%-58.66%

In the previous week, Talisman Metals had 1 more articles in the media than Genflow Biosciences. MarketBeat recorded 1 mentions for Talisman Metals and 0 mentions for Genflow Biosciences. Talisman Metals' average media sentiment score of 0.21 beat Genflow Biosciences' score of 0.00 indicating that Talisman Metals is being referred to more favorably in the media.

Company Overall Sentiment
Talisman Metals Neutral
Genflow Biosciences Neutral

Talisman Metals has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market. Comparatively, Genflow Biosciences has a beta of 2.297, meaning that its stock price is 130% more volatile than the broader market.

Summary

Talisman Metals beats Genflow Biosciences on 9 of the 11 factors compared between the two stocks.

Get Talisman Metals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLM vs. The Competition

Export
MetricTalisman MetalsBiotechnology IndustryHealthcare SectorLON Exchange
Market Cap£4.08M£3.74B£7.08B£2.89B
Dividend Yield0.83%3.76%2.58%6.09%
P/E Ratio0.5110.36268.52368.54
Price / SalesN/A1,273.20652.4983,661.83
Price / Cash1.00102.9470.5927.89
Price / Book2.6317.8213.147.24
Net Income-£1.35M-£13.23M£3.45B£5.89B
7 Day Performance0.16%3.00%1.83%1.25%
1 Month Performance-14.99%1.42%0.92%2.72%
1 Year PerformanceN/A55.38%67.70%70.10%

Talisman Metals Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLM
Talisman Metals
N/AGBX 6.35
+1.6%		N/AN/A£4.08MN/A0.515
CLBX
Cellbxhealth
N/AGBX 1.37
+1.5%		N/AN/A£15.57M£1.15MN/AN/A
APTA
Aptamer Group
N/AGBX 0.45
-1.1%		N/A-31.6%£15.55M£1.38MN/A37
FAB
Fusion Antibodies
N/AGBX 10.36
-3.7%		N/A-28.0%£13.45M£1.60MN/A48
NSCI
NetScientific
N/AN/AN/AN/A£12.81M£1.45MN/A26

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:TLM) was last updated on 8/13/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
What's the Best Way to Lower RMD Taxes?
Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accou...
SmartAsset | Sponsoredtc pixel